MARKET

SLNO

SLNO

Soleno Therapeutics Inc
NASDAQ
52.36
+0.01
+0.01%
Opening 09:53 04/08 EDT
OPEN
52.32
PREV CLOSE
52.35
HIGH
52.37
LOW
52.27
VOLUME
2.45M
TURNOVER
--
52 WEEK HIGH
90.32
52 WEEK LOW
29.43
MARKET CAP
2.70B
P/E (TTM)
133.93
1D
5D
1M
3M
1Y
5Y
1D
Largest borrow rate increases among liquid names
TipRanks · 1h ago
This Soleno Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Benzinga · 2h ago
Soleno Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones · 2h ago
Soleno Therapeutics Price Target Cut to $53.00/Share From $100.00 by HC Wainwright & Co.
Dow Jones · 2h ago
HC Wainwright & Co. Downgrades Soleno Therapeutics to Neutral, Lowers Price Target to $53
Benzinga · 2h ago
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Soleno Therapeutics (SLNO)
TipRanks · 3h ago
SOLENO THERAPEUTICS, INC. <SLNO.O>: H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY
Reuters · 3h ago
Soleno Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
TipRanks · 3h ago
More
About SLNO
Soleno Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing novel therapeutics for the treatment of rare diseases. The Company’s lead product candidate, diazoxide choline extended-release tablets (DCCR), is for the treatment of Prader-Willi syndrome (PWS) in individuals four years and older who have hyperphagia. DCCR contains diazoxide choline, a potent ATP-sensitive potassium (KATP) channel activator. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine. Its proposed mode of action, with targets in the brain, pancreas and fat tissue, has the potential to broadly impact complex diseases like PWS to reduce appetite, reduce food-seeking, decrease insulin and leptin resistance, and reduce body fat. The Company has Breakthrough Therapy and Fast-Track designations in the United States and Orphan Drug designations in the United States and European Union.

Webull offers Soleno Therapeutics Inc stock information, including NASDAQ: SLNO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLNO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLNO stock methods without spending real money on the virtual paper trading platform.